Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases

Gaiqin Pei1,2, Rui Liu1,2, Lu Wang1,2

  • 1Department of Rehabilitation Medicine and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.

BMC Cardiovascular Disorders
|September 11, 2023
PubMed

Insights

The monocyte to high-density lipoprotein ratio (MHR) independently predicts mortality and complications in coronary artery disease (CAD) patients. This association is particularly strong in individuals with hypertension.

Area of Science:

  • Cardiology
  • Biomarkers
  • Prognostic Indicators

Background:

  • The prognostic significance of the monocyte to high-density lipoprotein ratio (MHR) in coronary artery disease (CAD) remains unclear.
  • Existing research has not definitively established a link between MHR and patient outcomes in CAD.

Purpose of the Study:

  • To investigate the association between the monocyte to high-density lipoprotein ratio (MHR) and prognosis in patients with coronary artery disease (CAD).
  • To determine if MHR can predict all-cause mortality and in-hospital complications in CAD patients.

Main Methods:

  • A cohort study including 5371 patients with CAD.
  • Blood samples collected within 24 hours of admission.
  • Multivariate Cox regression and ROC analysis to assess MHR's predictive value for mortality and complications.

Main Results:

  • MHR was an independent predictor of all-cause mortality (HR 1.81), cardiovascular mortality (HR 1.69), and non-cardiovascular mortality (HR 2.04).
  • The association between MHR and mortality was significant in hypertensive patients (P for interaction=0.003).
  • Higher MHR levels correlated with increased risk of complications like infection, pneumonia, and gastrointestinal bleeding. MHR demonstrated superior prognostic value compared to individual monocyte and HDL levels.

Conclusions:

  • The monocyte to high-density lipoprotein ratio (MHR) serves as an independent predictor for all-cause mortality and in-hospital complications in CAD patients.
  • The prognostic value of MHR is especially pronounced in patients with co-existing hypertension.
  • MHR offers a valuable prognostic tool in managing coronary artery disease patients.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
188
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Inflammation01:38

Inflammation

Overview
53.8K